www.rsc.org

www.rsc.org
Share

www.rsc.org

 •  February 14

New government controls on cardiovascular and diabetes drugs challenged by industry lobby groups The Indian pharma industry is engaged in a pitched battle with the drug price regulator that recently brought certain drugs under price control. On 10 July, the National Pharmaceutical Pricing Authority (NPPA) issued an order bringing certain...

www.rsc.org

 •  February 14

Combinations of different firms’ drugs seek to reap immuno-oncology’s benefits Amid fierce rivalries over the latest generation of cancer treatments, drugmakers have been weaving a complex web of collaborations on combination therapies spanning much of the pharmaceutical industry. As the true significance for patients of molecules that recruit or...

www.rsc.org

 •  February 14

68 stalled pharmaceutical compounds are being made available for academic research through the UK Medical Research Council (MRC). Seven major drug companies, including AstraZeneca (AZ) and Pfizer, have partnered with the MRC to release molecules that dropped out of their pipelines. The new initiative takes its cue from an existing collaboration...